BIOA stock news · BioAge Labs
Get alerts for BIOA
Follow BioAge Labs (BIOA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BIOAFree on the App Store and Google Play, or on the web.
BioAge Labs is shifting its focus to eye health and delaying some heart studies while sharing updates on future plans.
NeutralBioAge Labs reported about $350 million in cash, expected to fund operations through 2029, and delayed ASCVD trials pending competitor data. These updates leave its outlook unchanged.